SAGE News
Archived Headlines
- Epilepsy biotech Marinus Pharmaceuticals sets terms for $52 million IPO 07/18/14
- Sage Therapeutics increases proposed IPO deal size 07/17/14
- 11 US IPOs planned for the week of Jul 14 07/14/14
- Seizure biotech Sage Therapeutics sets terms for $60 million IPO 07/08/14
- Biotech Sage Therapeutics files for a $69 million IPO to fund treatments for deadly seizures 06/17/14
Epilepsy device maker NeuroSigma sets terms for $50 million IPO
NeuroSigma, which develops electrical devices used to treat drug-resistant epilepsy and depression, announced terms for its IPO on Monday. The Los Angeles, CA-based company plans to raise $50 million by offering 3.6 million shares at a price range of $13 to $15....read more
Epilepsy device maker NeuroSigma files for a $50 million IPO
NeuroSigma, which develops electrical devices used to treat drug-resistant epilepsy and depression, filed on Tuesday with the SEC to raise up to $50 million in an initial public offering. The company is in pivotal trials to have its bioelectronic products...read more
July could reach 40 IPOs
Our loaded IPO calendar indicates that July could have the most IPOs in a single month in fourteen years, immediately after last quarter set a similar record. As many as 23 IPOs could price next week. Only one time since 2000 (in December 2004) has a week...read more
US IPO Recap: Biotech Sage and adtech TubeMogul pop over 60% on first day
On Tuesday, the chair of the Federal Reserve warned that valuations in biotech stocks were stretched, which sparked a selloff across the sector. On Friday, the week's only biotech IPO, Sage Therapeutics (SAGE), spiked 67% on its first day of trading after it...read more